Pentoxifylline Role Against Chemotherapy-induced Neuropathy

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

April 1, 2024

Study Completion Date

August 1, 2024

Conditions

Chemotherapy-induced Peripheral Neuropathy

Interventions

DRUG

Pentoxifylline

Pentoxifylline 400mg twice daily plus paclitaxel based regimens for 12weeks.

Trial Locations (1)

University Hospital, Banī Suwayf

All Listed Sponsors

lead

Beni-Suef University

OTHER